Derimanov S G
Nucl Med Commun. 1987 Feb;8(2):79-86. doi: 10.1097/00006231-198702000-00005.
Present opinions about the efficacy of bone scintigraphy of patients with breast cancer are widely different. The present article is an attempt to assess the possibilities of such a test through a retrospective analysis of bone scintigraphies of 422 patients with breast cancer made during the course of 6 years. The scintigrams were positive in 30.6% of the patients who have had symptoms from any part of their bone system and only in 6.1% of the patients with no complaints. The percentage of positive scintigrams varies from 14.3 to 42.1% depending on the stage of the cancer. All patients scanned before their operation had normal scintigrams; metastases in the bones appeared after the intervention. The time for the appearance of bone metastases in the different groups varies between 20.7 and 50.9 months. In conclusion we confirm those cases in which bone scintigraphy is applicable.
目前对于乳腺癌患者骨闪烁扫描术疗效的观点差异很大。本文试图通过回顾性分析422例乳腺癌患者在6年期间进行的骨闪烁扫描结果，来评估该项检查的可能性。在有骨系统任何部位症状的患者中，闪烁扫描图阳性率为30.6%，而在无任何不适的患者中仅为6.1%。根据癌症分期不同，闪烁扫描图阳性率在14.3%至42.1%之间变化。所有术前进行扫描的患者闪烁扫描图均正常；骨转移在手术后出现。不同组中骨转移出现的时间在20.7至50.9个月之间。总之，我们确认了骨闪烁扫描术适用的那些病例。
